Gluteus Medius Latent Trigger Point and Muscle Strength in Healthy Subjects

Muscle Weakness Clinical Trial

Official title:

The Relationship Between Gluteus Medius Latent Trigger Point and Muscle Strength in Healthy Subjects

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04640558
• Other study ID #: KarsSH
• Status: Completed
• Start date: November 17, 2020
• Est. completion date: January 17, 2021

Study information

• Verified date: January 2021
• Source: Kars State Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

This study aimed to investigate the relationship between latent MTrPs and gluteus medius muscle strength in a group of healthy adults.

Description:

Latent myofascial trigger points (MTrPs) do not cause spontaneous pain; however, they may lead to a limited range of motion and muscle weakness. We hypothesized that latent MTrPs might decrease gluteus medius muscle strength in healthy individuals. Forty-eight healthy men will be included in the study. Trigger point examination for the gluteus medius will be performed bilaterally. Subjects with one or more trigger points on the dominant side and those without any trigger points will be assigned to two groups. Muscle strength for gluteus medius will be assessed with a manual muscle tester using the "break test" technique on both sides. The subjects and the examiners will be blinded. For statistical analysis, the independent sample t-test was used to compare the intergroup differences.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 48
• Est. completion date: January 17, 2021
• Est. primary completion date: January 17, 2021
• Gender: Male
• Age group: 18 Years to 40 Years

Eligibility

Inclusion Criteria:

• Patient age: 18-40 years.
• Absence of musculoskeletal complaints related to the lumbar, sacroiliac, and hip area.
• Absence of bilateral latent MTrP in the gluteus medius muscle.
• Latent trigger point in the gluteus medius muscle on the dominant side with palpation.

Exclusion Criteria:

• A history of medical treatment, physical therapy, injection therapy, or surgical treatment related to the lumbar, sacroiliac, and hip area.
• History of trauma, or malignancy or being pregnant, or if the patient is in the lactation period.
• Bilateral latent MTrP in the gluteus medius muscle.
• Presence of latent MTrP on the non-dominant side.

Related Conditions & MeSH terms

• Fibromyalgia
• Muscle Weakness
• Myofascial Pain Syndrome
• Myofascial Pain Syndromes

Intervention

Device:
• Muscle strength measurement
The bilateral gluteus medius muscle strength of each participant will be measured by the assessor (MB) blinded to the participants using the Lafayette manual muscle tester. (Lafayette Instrument Company, Lafayette IN, USA). In the participant's side-lying position, the practitioner applied resistance from the upper ankle to the abduction movement with slight flexion of the upper hip. During the measurements, the participants were asked to perform the maximum isometric contraction for 3 seconds. Gluteus medius muscle strength measurements were repeated three times, one minute apart, on the right and left sides. The mean of the measurements was calculated and recorded

Locations

Country	Name	City	State
Turkey	Biruni University Faculty of Medicine	Istanbul

Sponsors (1)

Lead Sponsor	Collaborator
Kars State Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Gluteus medius muscle strength	In the participant's side-lying position, the practitioner will be applied resistance from the upper ankle to the abduction movement with slight flexion of the upper hip. During the measurements, the participants will be asked to perform the maximum isometric contraction for 3 seconds. Gluteus medius muscle strength measurements will be repeated three times, one minute apart, on the right and left sides. The mean of the measurements will be calculated and recorded	One month